HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Equities researchers at HC Wainwright issued their Q1 2026 EPS estimates for HIVE Blockchain Technologies in a research note issued to investors on Thursday, November 14th. HC Wainwright analyst M. Colonnese forecasts that the company will post earnings per share of ($0.04) for the quarter. HC Wainwright currently has a “Strong-Buy” rating on the stock. HC Wainwright also issued estimates for HIVE Blockchain Technologies’ Q2 2026 earnings at $0.00 EPS, Q3 2026 earnings at $0.06 EPS and FY2026 earnings at $0.06 EPS.
HIV has been the subject of several other research reports. Cantor Fitzgerald raised shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Tuesday, October 29th. Northland Capmk upgraded shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Thursday, September 19th.
HIVE Blockchain Technologies Stock Performance
HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.
Further Reading
- Five stocks we like better than HIVE Blockchain Technologies
- How to Calculate Options Profits
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- How to Use the MarketBeat Excel Dividend Calculator
- Top-Performing Non-Leveraged ETFs This Year
- Do ETFs Pay Dividends? What You Need to Know
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
